Dr. Kevin Bethel

Dr. Kevin Bethel

MD CM FAARM FICT

Dr. Kevin Bethel has been doing various forms of immune therapy for cancer for almost 10 years. He is the first doctor outside of China to be granted permission to use Gendicine; and through his certification from Latvia to use RigVir, he is the only doctor in the world with clinical experience in both licensed virotherapies.

Dr. Bethel continues to be involved in research in other immune therapies, including Site Specific Immune Therapy with Dr. Hal Gunn in Vancouver and over 10 years clinical experience with MBVax Coley’s immune therapy. For the past four years, he has been working at the Immune Augmentative Therapy (IAT) Centre to further research the immune therapies Dr. Burton and Dr. John Clement started researching almost 40 years ago, including a simple cost-effective form of dendritic cell immune therapy.